X

LUPIN

Lupin Ltd (LUPIN) Q3 2026 Earnings Call Transcript

Lupin Ltd (NSE: LUPIN) Q3 2026 Earnings Call dated Feb. 13, 2026 Corporate Participants: Vinita Gupta — Chief Executive Officer…

Earnings Summary – Lupin Limited Reports 26.4% Revenue Growth in Third Quarter FY2026

Lupin Limited (NSE: LUPIN) is a global pharmaceutical company specializing in branded and generic formulations, biotechnology, and active pharmaceutical ingredients.…